Testicular Cancer: A Prototypic Tumor of Young Adults

被引:85
作者
Hayes-Lattin, Brandon [1 ]
Nichols, Craig R. [2 ]
机构
[1] Oregon Hlth & Sci Univ, Knight Canc Inst, Portland, OR 97201 USA
[2] Providence Canc Ctr, Earle A Chiles Res Inst, Portland, OR USA
关键词
LONG-TERM SURVIVORS; GERM-CELL TUMORS; CISPLATIN; CHEMOTHERAPY; CARBOPLATIN; BLEOMYCIN; ETOPOSIDE; THERAPY;
D O I
10.1053/j.seminoncol.2009.07.006
中图分类号
R73 [肿瘤学];
学科分类号
100214 [肿瘤学];
摘要
Testicular cancer is the most common solid tumor among males in the 20- to 39-year age range. Moreover, testicular cancer has unique biological associations, clinical features, and psychosocial impacts that establish this tumor as a prototypic malignancy of young adults. The biology of testicular germ cell tumors after puberty is distinctive. Epidemiologic patterns of testicular cancer suggest etiologic factors that may be congenital, racial, and geographic. The clinical management of a cancer common among young adults, but rare among adults in general, requires expertise so as not to jeopardize the high rates of survivorship associated with modern therapy. The concurrent but separate development of staging, prognostic systems, and treatment recommendations between the fields of pediatric and adult oncology highlights the need for increased integration and cooperation across these subspecialties. The high rate of survival, combined with the need for long-term monitoring for relapse or late effects, demonstrates the challenge of delivering longitudinal care in this mobile and active young adult population. © 2009 Elsevier Inc. All rights reserved.
引用
收藏
页码:432 / 438
页数:7
相关论文
共 38 条
[1]
[Anonymous], 1997, J Clin Oncol, V15, P594
[2]
[Anonymous], 1975, SEER CANC STAT REV
[3]
BAJORIN DF, 1991, CANCER, V67, P28, DOI 10.1002/1097-0142(19910101)67:1<28::AID-CNCR2820670106>3.0.CO
[4]
2-3
[5]
Improved clinical outcome in recent years for men with metastatic nonseminomatous germ cell tumors [J].
Carver, Brett S. ;
Serio, Angel M. ;
Bajorin, Dean ;
Motzer, Robert J. ;
Stasi, Jason ;
Bosl, George J. ;
Vickers, Andrew J. ;
Sheinfeld, Joel .
JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (35) :5603-5608
[6]
CHAGANTI RSK, 1993, UROL CLIN N AM, V20, P55
[7]
Equivalence of three or four cycles of bleomycin, etoposide, and cisplatin chemotherapy and of a 3- or 5-day schedule in good-prognosis germ cell cancer:: A randomized study of the European organization for research and treatment of cancer genitourinary tract cancer cooperative group and the medical research council [J].
de Wit, R ;
Roberts, JT ;
Wilkinson, PM ;
de Mulder, PHM ;
Mead, GM ;
Fosså, SD ;
Cook, P ;
de Prijck, L ;
Stenning, S ;
Collette, L .
JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (06) :1629-1640
[8]
ACUTE VASCULAR ISCHEMIC EVENTS AFTER CISPLATIN-BASED COMBINATION CHEMOTHERAPY FOR GERM-CELL TUMORS OF THE TESTIS [J].
DOLL, DC ;
LIST, AF ;
GRECO, FA ;
HAINSWORTH, JD ;
HANDE, KR ;
JOHNSON, DH .
ANNALS OF INTERNAL MEDICINE, 1986, 105 (01) :48-51
[9]
TESTICULAR TUMORS FOLLOWING ORCHIOPEXY [J].
DOW, JA ;
MOSTOFI, FK .
SOUTHERN MEDICAL JOURNAL, 1967, 60 (02) :193-&
[10]
FALLON R, 2006, NIH PUB